. 2017 Nov 10;7:15279. doi: 10.1038/s41598-017-13148-y

Table 4.

Comparison of antimicrobial susceptibilities of blood isolates in survivors and non-survivors.

Antimicrobial agent	Survivors		non-survivors		X²	P value
Antimicrobial agent	R%	MIC₅₀/MIC₉₀	R%	MIC₅₀/MIC₉₀	X²	P value
cefepime	94.29	64/≥128	96.08	64/≥128	0.150	0.698
ceftriaxone	97.14	≥128/≥128	96.08	≥128/≥128	0.070	0.792
ciprofloxacin	94.29	≥16/≥16	96.08	≥16/≥16	0.150	0.698
imipenem	94.29	32/≥128	96.08	32/≥128	0.150	0.698
piperacillin/tazobactam	97.14	≥512/4/≥512/4	96.08	≥512/4/≥512/4	0.070	0.792
gentamicin	88.57	32/≥128	90.20	32/≥128	0.537	0.464
tobramycin	82.86	32/≥128	90.20	32/≥128	1.202	0.273
levofloxacin	57.14	8/≥32	54.90	8/≥32	0.042	0.837
tigecycline	20.00	1/4	23.53	1/4	0.150	0.698
cefperazone/sulbactam	82.86	64/128	90.20	64/≥256	1.002	0.317
minocyline	47.37	8/16	55.00	16/32	0.227	0.634
amikacin	64.71	128/≥512	66.67	128/≥512	0.014	0.907
ceftazidime	94.29	64/≥128	98.04	≥128/≥128	0.869	0.351
ampicillin/sulbactam	91.43	128/256	96.07	128/≥512	0.820	0.365
meropenem	94.29	≥32/≥32	96.08	≥32/≥32	0.150	0.698
polymyxin B	0	2/2	5.88	2/2	2.133	0.144